• Dr. Sabrina Badir

    CEO / Founder 

  • Dr. Francisco delgado

    VP R&D / Founder

  • Isabella Moser

    Quality Assurance / Regulatory Affairs Manager

  • Clemens Clausen

    Senior Design Engineer

  • Ralph Rechsteiner

    Junior Medical Engineer

  • Dr. Laura Bernardi

    Product Manager

  • Marlene Bissig

    Application Specialist, Communication

  • Bruno Candrian

    VP Marketing & Sales

  • Fabienne Wiggenhauser

    Marketing & Sales Assistant

  • Pamela unternährer

    VP Clinical & Medical Affairs

Board of Directors

  • Dr. Sabrina Badir

    Chairwoman of the Board

  • Dr. Marc Kohler

    Member of the Board

  • Prof. Dr. Bruno Reihl

    Member of the Board


Pregnolia is an ETH Spin-off that has developed a device to improve pregnancy care. It was founded in 2016, originating in the PhD thesis of Sabrina Badir. She was part of the interdisciplinary research team at ETH Zürich and the University Hospital in Zürich that studied the changes in stiffness of the human uterine cervix during pregnancy. The goal was to detect earlier and more accurately these changes. Cervical stiffness is one of the important factors that determine the risk of preterm birth.


The team has since grown, combining scientific, technical and medical know-how.

Quality Management

Pregnolia has established a quality management system according to the standard EN ISO 13485:2016.

This certification demonstrates that Pregnolia is compliant with the requirements for a quality management system used in the design and manufacture of medical devices.


The Pregnolia products are CE certified (Directive 93/42/EEC on Medical Devices).



Terms and Conditions

​Our polices, terms and conditions are available on the following links:

© 2021 by Pregnolia | Privacy Policy